Keiji Kuwabara

Awards Nomination 25+ Million Readerbase

Google Scholar citation report

Citations : 1221

Journal of Nanomedicine & Biotherapeutic Discovery received 1221 citations as per Google Scholar report

Journal of Nanomedicine & Biotherapeutic Discovery peer review process verified at publons

Indexed In

Open J Gate

Genamics JournalSeek

ResearchBible

China National Knowledge Infrastructure (CNKI)

Ulrich's Periodicals Directory

RefSeek

Hamdard University

EBSCO A-Z

OCLC- WorldCat

Publons

Euro Pub

Google Scholar

Useful Links

Covid-19 Journal Articles Issues Aim and Scope Peer Review Process Other Comments Advertising Citations Report Indexing and Archiving Table of Contents Submit Paper Track Your Paper Funded Work

Share This Page

Recommended Journals

Nano-medicine and Biotherapeutics Journal Drug Design Journal Bioinformatics Journal Toxicology Journal

25+ Million Website Visitors

Journal Flyer

Tweets by j_nanomedicine

Open Access Journals

Agri and Aquaculture Biochemistry Bioinformatics & Systems Biology Business & Management Chemistry Clinical Sciences Engineering Food & Nutrition General Science Genetics & Molecular Biology Immunology & Microbiology Medical Sciences Neuroscience & Psychology Nursing & Health Care Pharmaceutical Sciences

Keiji Kuwabara

Inhibitory Effects of Trehalose Liposomes against Breast Cancer Cells Leading to Apoptosis in vitro

Biography

Keiji Kuwabara, is working as an Assistant Professor at Department of Chemistry, Drexel University, USA. He is having experience of more than 10years and he had attended many International Conferences and chair the sessions.

Relevant Topics

Antibodies Drug Conjugates Antigen ÃÂ¢Ãâ¬Ãâ Antibody Reaction Applications of Bioinformatics Biochemical Metabolism Bioinformatics Algorithms Bioinformatics Databases Bioinformatics Tools Cancer Proteomics Clinical Biotherapeutics Clinical Proteomics Current Proteomics Cytochrome 450 Drug Metabolism Cytotoxicity Detoxification Drug Delivery Systems Drug Delivery using Nanotechnology Drug Designing Drug Development Drug Discovery Drug Interaction Drug Interactions Drug Metabolism Drug Therapy Drug Toxicology Drug drug interaction Drug food interaction Drugs metabolised by CYP2D6 Experts Opinion on Nanomedicine Fragment Based Drug Design Heat Shock Proteins Hepatic Metabolism of Drugs Human Proteome Project Applications Implementation and Implications of Nanomedicine In Silico Methods Lipid based Nanoparticles Liver Drug Metabolism Mass Spectrometry in Proteomics Microarray Proteomics Molecular Modeling Molecular and Cellular Proteomics Nanobiopharmaceuticals Nanoemulsions Nanomedical Tools in Gene Therapy Nanomedicals Nanomedicine Nanomedicine Applications Nanomedicine and Nanobiotechnology Nanomedicine in Cancer Nanomedicine in Drug Discovery Nanoparticles and Biocompatibility Nanotechnology Peptidomimetic Pharmaceutical Industry Pharmaceutical Toxicology Phase I Drug Metabolism Phase II Drug Metabolism Polymeric Nanoparticle Delivery Pre-Clinical Drug Development Protease Substrate/Inhibitor Protein Sequence Analysis Proteome Profiling Proteomic Analysis Proteomic Biomarkers Proteomics Clinical Applications Proteomics Research Proteomics Science Python for Bioinformatics Quantitative Proteomics Receptor Agonist/ Antagonist Solid Lipid Nanoparticles Structure Based Drug Design Therapeutic Agents Toxicity of Nanomaterials screening and Drug Design

Journal of Nanomedicine & Biotherapeutic DiscoveryOpen Access

Keiji Kuwabara

Biography

Relevant Topics

Journal of Nanomedicine & Biotherapeutic Discovery
Open Access